ARGENT BIOPHARMA LIMITED ORD NPV (DI) revenue breakdown overview

ARGENT BIOPHARMA LIMITED ORD NPV (DI) revenue for the last year amounted to 1.78 M GBP, the most of which — 1.32 M GBP — came from its highest performing source at the moment, Cannabinoids, the year earlier bringing 2.28 M GBP. The greatest contribution to the revenue figure was made by Slovenia — last year it brought ARGENT BIOPHARMA LIMITED ORD NPV (DI) 1.49 M GBP, and the year before that — 1.83 M GBP.